Oophorectomy News and Research RSS Feed - Oophorectomy News and Research

Oophorectomy is the surgical removal of an ovary or ovaries. The surgery is also called ovariectomy, but this term has been traditionally used in basic science research describing the surgical removal of ovaries in laboratory animals.
Study suggests ovary removal to prevent ovarian cancer should be discontinued in premenopausal women

Study suggests ovary removal to prevent ovarian cancer should be discontinued in premenopausal women

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer. [More]
Shorter and longer reproductive durations can raise risk of type 2 diabetes in postmenopausal women

Shorter and longer reproductive durations can raise risk of type 2 diabetes in postmenopausal women

Using data from the Women's Health Initiative, a new study has found that women with reproductive-period durations of less than 30 years had a 37% increased risk of type 2 diabetes compared with women whose reproductive durations were somewhere in the middle (36 to 40 years). [More]
Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Great question – the answer is actually unknown. Every month, there are publications that report on new cancer-related genes, so it's an area of great knowledge growth at the moment. [More]
New research reveals advances that could change gynecologic cancer standard-of-care treatments

New research reveals advances that could change gynecologic cancer standard-of-care treatments

Advances that could change gynecologic cancer standard-of-care treatments are the centerpiece of key studies being presented by researchers from The University of Texas MD Anderson Cancer Center's Department of Gynecologic Oncology and Reproductive Medicine at the 2016 Annual Meeting of the American Society of Clinical Oncology. [More]
BRCA gene mutations raise risk of breast, ovarian and other cancers

BRCA gene mutations raise risk of breast, ovarian and other cancers

BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. [More]
Oophorectomy could increase colorectal cancer risk in both pre- and postmenopausal women

Oophorectomy could increase colorectal cancer risk in both pre- and postmenopausal women

Colorectal cancer may rise in women who have their ovaries removed, according to new research. [More]
Genetic test use rises in young US breast cancer patients

Genetic test use rises in young US breast cancer patients

BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions. [More]
Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

Quest Diagnostics, the world’s leading provider of diagnostic information services, and Inserm, the French National Institute of Health and Medical Research institution, today launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. [More]
EMAS position statement on ten-point guide to integral management of menopausal health published

EMAS position statement on ten-point guide to integral management of menopausal health published

Elsevier journal Maturitas, today announced the publication of a position statement by the European Menopause and Andropause Society covering the ten- point guide to the integral management of menopausal health. [More]
Surprise WHI finding points to age, not menopause, as a risk factor for pelvic organ prolapse

Surprise WHI finding points to age, not menopause, as a risk factor for pelvic organ prolapse

Removing ovaries at hysterectomy does not increase a woman's risk of pelvic organ prolapse after menopause. In fact, removing ovaries lowers the risk of prolapse. This surprising finding from a Women's Health Initiative study was published online this week in Menopause, the journal of The North American Menopause Society. [More]
Half-day educational program can help educate women on side effects of cancer prevention surgery

Half-day educational program can help educate women on side effects of cancer prevention surgery

More women are having ovary-removing surgery as a cancer prevention measure, but many are often unaware of sexual or psychological side effects of the procedure. A new study by researchers at Dana-Farber Cancer Institute shows a half-day educational program can help successfully deal with these issues by educating women on how to address them. [More]
Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

For benign gynecologic conditions, robot-assisted surgery involves more complications during surgery and may be significantly more expensive than conventional laparoscopic surgery, according to a study by researchers at Columbia University Medical Center. [More]
RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

Radiation therapy with concurrent paclitaxel chemotherapy following surgery is an effective treatment for patients with high-risk endometrial cancer, according to a study published in the September 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). [More]
New guideline recommends genetic testing of tumors for colorectal cancer patients

New guideline recommends genetic testing of tumors for colorectal cancer patients

Of the 143,000 patients diagnosed with colorectal cancer annually in the U.S., up to 25 percent have a familial risk of colorectal cancer. A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients. [More]
BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Inherited mutations in the BRCA1 or BRCA2 tumor suppressor genes are by far the most frequent contributors to hereditary cancer risk in the human population, often causing breast or ovarian cancer in young women of child-bearing age. [More]
Discovery could lead to major breakthrough in breast and ovarian cancer

Discovery could lead to major breakthrough in breast and ovarian cancer

Cancer researchers at Queen's University Belfast have made a breakthrough which could signal new treatments for women at high risk of breast and ovarian cancer. [More]
Women with BRCA1 mutations may have increased risk for rare types of aggressive uterine cancer

Women with BRCA1 mutations may have increased risk for rare types of aggressive uterine cancer

Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings being presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Tampa, Fla., March 22-25. [More]
Preventive oophorectomy reduces risks of ovarian, breast cancers in women with BRCA mutation

Preventive oophorectomy reduces risks of ovarian, breast cancers in women with BRCA mutation

Women who carry a BRCA gene mutation and opt for a preventive oophorectomy, or ovary removal surgery, have a 77 per cent lower risk of death than those who do not, according to a new study led by Women's College Hospital's Amy Finch and Dr. Steven Narod. [More]
Study: Women with BRCA1 mutations should have preventive ovarian surgery by age 35

Study: Women with BRCA1 mutations should have preventive ovarian surgery by age 35

The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery. [More]
New studies offer hope to women who want to get sexual mojo back

New studies offer hope to women who want to get sexual mojo back

For women, passing midlife can deal a blow to their sex drive. But two new studies just published online in Menopause, the journal of The North American Menopause Society, offer hope to women who want to get their sexual mojo back. [More]
Advertisement
Advertisement